Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
tests decrease » costs decreased (Expand Search), teer decrease (Expand Search), visits decreased (Expand Search)
Showing 1,661 - 1,680 results of 21,342 for search '(( significant decrease decrease ) OR ( significance ((tests decrease) OR (greater decrease)) ))', query time: 0.42s Refine Results
  1. 1661
    Forest plot between UCAR and cognitive impairment.

    Forest plot between UCAR and cognitive impairment. by Yubo Teng (21246745)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1662
    Flowchart of participants in this study.

    Flowchart of participants in this study. by Yubo Teng (21246745)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1663
    Nonlinear relationship between UACR and cognitive impairment.

    Nonlinear relationship between UACR and cognitive impairment. by Yubo Teng (21246745)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1664
    Threshold effect analysis of UACR and cognitive impairment.

    Threshold effect analysis of UACR and cognitive impairment. by Yubo Teng (21246745)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1665
    Analyzing the relationship between UACR (<30) and cognitive scores and impairment.

    Analyzing the relationship between UACR (<30) and cognitive scores and impairment. by Yubo Teng (21246745)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1666
    Analyzing the relationship between UACR and cognitive scores and impairment.

    Analyzing the relationship between UACR and cognitive scores and impairment. by Yubo Teng (21246745)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1667
    Baseline characteristics of participants (N = 2385) by UACR.

    Baseline characteristics of participants (N = 2385) by UACR. by Yubo Teng (21246745)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1668
    Trends of incident opioid users, L-TOT users, and L-TOT discontinuers between 2009 and 2013.

    Trends of incident opioid users, L-TOT users, and L-TOT discontinuers between 2009 and 2013. by Qian Cai (112039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1669
    The yearly numerator, denominator and rate of incident opioid users, L-TOT users and L-TOT discontinuers from 2009 to 2019.

    The yearly numerator, denominator and rate of incident opioid users, L-TOT users and L-TOT discontinuers from 2009 to 2019. by Qian Cai (112039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1670
    Incidence rate ratios of negative binominal regression models for yearly rates of incident opioid users, L-TOT users and L-TOT discontinuers during 2009–2013 and 2015–2019.

    Incidence rate ratios of negative binominal regression models for yearly rates of incident opioid users, L-TOT users and L-TOT discontinuers during 2009–2013 and 2015–2019. by Qian Cai (112039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1671
    Demographic, comorbidity, concurrent drug, and opioid characteristics, among L-TOT users and L-TOT discontinuers between 2009–2019.

    Demographic, comorbidity, concurrent drug, and opioid characteristics, among L-TOT users and L-TOT discontinuers between 2009–2019. by Qian Cai (112039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1672
    Cytotoxicity (as of %Control) IC<sub>50</sub> value (mean ±SD in µM) of the tested compounds vs. Positive controls Cisplatin and doxorubicin against gastrointestinal and colorectal malignancies’ adherent monolayers.

    Cytotoxicity (as of %Control) IC<sub>50</sub> value (mean ±SD in µM) of the tested compounds vs. Positive controls Cisplatin and doxorubicin against gastrointestinal and colorectal... by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1673
    The influence of 5-HT on MSQ43 cells.

    The influence of 5-HT on MSQ43 cells. by Li Gao (131516)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 1674
    The influence of fluoxetine treatment on <i>P</i>. <i>berghei</i> pathogenesis.

    The influence of fluoxetine treatment on <i>P</i>. <i>berghei</i> pathogenesis. by Li Gao (131516)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 1675
    5-HT supplementation inhibits mitophagy.

    5-HT supplementation inhibits mitophagy. by Li Gao (131516)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 1676
    The influence of 5-HT in mice serum on <i>Plasmodium</i> infection in mosquitoes.

    The influence of 5-HT in mice serum on <i>Plasmodium</i> infection in mosquitoes. by Li Gao (131516)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 1677
    5-HT- induced mitochondrial ROS inhibits <i>P</i>. <i>berghei</i> infection.

    5-HT- induced mitochondrial ROS inhibits <i>P</i>. <i>berghei</i> infection. by Li Gao (131516)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 1678
    The influence of H<sub>2</sub>O<sub>2</sub> on <i>P</i>. <i>berghei</i> infection in <i>A</i>. <i>stephensi</i>.

    The influence of H<sub>2</sub>O<sub>2</sub> on <i>P</i>. <i>berghei</i> infection in <i>A</i>. <i>stephensi</i>. by Li Gao (131516)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 1679
    5-HT inhibits <i>P</i>. <i>berghei</i> infection in mosquitoes.

    5-HT inhibits <i>P</i>. <i>berghei</i> infection in mosquitoes. by Li Gao (131516)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 1680
    5-HT supplementation induces mitochondrial damage.

    5-HT supplementation induces mitochondrial damage. by Li Gao (131516)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: